Clinical Trials Directory

Trials / Completed

CompletedNCT01443494

High MAP in Septic Shock With Hypertension

High Mean Arterial Pressure Target Improves Microcirculation in Septic Shock Patients With Previous Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.

Detailed description

The effect of mean arterial pressure (MAP) titration to higher level on microcirculation in septic shock patients with previous hypertension remains unknown. Our goal was to assess the effect of MAP titration to patients' usual level on microcirculation in septic shock patients with previous hypertension. We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.

Conditions

Interventions

TypeNameDescription
OTHERNEnorepinephine

Timeline

Start date
2011-06-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2011-09-29
Last updated
2017-07-06
Results posted
2014-06-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01443494. Inclusion in this directory is not an endorsement.

High MAP in Septic Shock With Hypertension (NCT01443494) · Clinical Trials Directory